FDA restricts Johnson & Johnson's COVID vaccine due to blood clot risk
U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
More Videos
From CNN Newsource affiliates